Schedule 13G ownership disclosure

Candel Therapeutics Inc

Common Stock, par value $0.01 per share · CUSIP: 137404109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Baker Bros. Advisors LP

    Shares: 2,981,983.00 · Class: 6.8%

  • Baker Bros. Advisors (GP) LLC

    Shares: 2,981,983.00 · Class: 6.8%

  • Julian C. Baker

    Shares: 2,981,983.00 · Class: 6.8%

  • Felix J. Baker

    Shares: 2,981,983.00 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014091
Form type
SCHEDULE 13G
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub